All sponsors

Wuhan Createrna Science and Technology Co., Ltd

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS6
PHASE 3 / 2-34
RECRUITING3
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO17%

Delay Index: of 6 active trials registered more than a year ago, 1 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Wuhan Createrna Science and Technology Co., Ltd on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
MY008211A tablets
NCT06932744
P3RecruitingParoxysmal Nocturnal Haemoglobinuria (PNH)662025-12-30
MY008211A tablets
NCT06932471
P3RecruitingParoxysmal Nocturnal Hemoglobinuria202025-12-30
QR12000 75mg
NCT06716970
P3Not yet recruitingEssential Hypertension8102026-04-30
MY008211A tablets
NCT06687174
P2Not yet recruitingIgA Nephropathy (IgAN)722026-06-15
MY008211A tablets
NCT06933914
P2/3RecruitingParoxysmal Nocturnal Hemoglobinuria (PNH)1202026-12-30
MY008211A tablets
NCT06134414
P2Not yet recruitingParoxysmal Nocturnal Hemoglobinuria (PNH)402027-07 (+24 mo)